Evidence map›Paper›PMID 24330424›Full record

ArticleBMC microbiology2013

Molecular analysis and distribution of multidrug-resistant Enterococcus faecium isolates belonging to clonal complex 17 in a tertiary care center in Mexico City.

Sara A Ochoa, Gerardo Escalona, Ariadnna Cruz-Córdova, Leticia B Dávila, Zeus Saldaña, Vicenta Cázares-Domímguez, Carlos A Eslava, Briceida López-Martínez, Rigoberto Hernández-Castro, Guillermo Aquino-Jarquin and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Clinical and microbiological profile of Enterococcus faecium infections in Mexican pediatric patients of a third-level hospital.International microbiology : the official journal of the Spanish Society for Microbiology · 2025
    Article
  3. Article
  4. Heterogeneity and metabolic diversity amongMicrobiology spectrum · 2025
    Article
  5. Article
  6. Article
  7. Microorganisms · 2021
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Clonal Diversity in Multi Drug Resistant (MDR) Enterococci Isolated from Fecal Normal Flora.International journal of molecular and cellular medicine · 2015
    Article
  16. Clonal dissemination of vancomycin-resistant Enterococcus faecium ST412 in a Brazilian region.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Sara A Ochoa
Gerardo Escalona
Ariadnna Cruz-Córdova
Leticia B Dávila
Zeus Saldaña
Vicenta Cázares-Domímguez
Carlos A Eslava
Briceida López-Martínez
Rigoberto Hernández-Castro
Guillermo Aquino-Jarquin
Juan Xicohtencatl-CortesDepartamento de Infectología, Laboratorio de Bacteriología Intestinal, Hospital Infantil de México Federico Gómez, México City, DF 06720, México. juanxico@yahoo.com.
Hospital Infantil de México Federico Gómez · MXHospital General Dr. Manuel Gea Gonzalez · MXUniversidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEnterococcus faecium has recently emerged as a multidrug-resistant nosocomial pathogen involved in outbreaks worldwide. A high rate of resistance to different antibiotics has been associated with virulent clonal complex 17 isolates carrying the esp and hyl genes and the purK1 allele.

resultsTwelve clinical vancomycin-resistant Enterococcus faecium (VREF) isolates were obtained from pediatric patients at the Hospital Infantil de México Federico Gómez (HIMFG). Among these VREF isolates, 58.3% (7/12) were recovered from urine, while 41.7% (5/12) were recovered from the bloodstream. The VREF isolates showed a 100% rate of resistance to ampicillin, amoxicillin-clavulanate, ciprofloxacin, clindamycin, chloramphenicol, streptomycin, gentamicin, rifampicin, erythromycin and teicoplanin. In addition, 16.7% (2/12) of the isolates were resistant to linezolid, and 66.7% (8/12) were resistant to tetracycline and doxycycline. PCR analysis revealed the presence of the vanA gene in all 12 VREF isolates, esp in 83.3% (10/12) of the isolates and hyl in 50% (6/12) of the isolates. Phylogenetic analysis via molecular typing was performed using pulsed-field gel electrophoresis (PFGE) and demonstrated 44% similarity among the VREF isolates. MLST analysis identified four different sequence types (ST412, ST757, ST203 and ST612).

conclusionThis study provides the first report of multidrug-resistant VREF isolates belonging to clonal complex 17 from a tertiary care center in Mexico City. Multidrug resistance and genetic determinants of virulence confer advantages among VREF in the colonization of their host. Therefore, the prevention and control of the spread of nosocomial infections caused by VREF is crucial for identifying new emergent subclones that could be challenging to treat in subsequent years.

Indexed as

Drug Resistance, Multiple, BacterialAnti-Bacterial AgentsBloodCross InfectionDNA, BacterialElectrophoresis, Gel, Pulsed-FieldEnterococcus faeciumGenes, BacterialGram-Positive Bacterial InfectionsHospitals, PediatricHumansMexicoMicrobial Sensitivity TestsMolecular EpidemiologyMultilocus Sequence TypingPhylogenyAnti-Bacterial AgentsDNA, Bacterial

Identifiers

PMID24330424
PMCPMC4029522
OpenAlexW2143645730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.